These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20688924)

  • 1. Depression and functional status are strongly associated with dyspnea in interstitial lung disease.
    Ryerson CJ; Berkeley J; Carrieri-Kohlman VL; Pantilat SZ; Landefeld CS; Collard HR
    Chest; 2011 Mar; 139(3):609-616. PubMed ID: 20688924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression is a common and chronic comorbidity in patients with interstitial lung disease.
    Ryerson CJ; Arean PA; Berkeley J; Carrieri-Kohlman VL; Pantilat SZ; Landefeld CS; Collard HR
    Respirology; 2012 Apr; 17(3):525-32. PubMed ID: 22221976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty is common and strongly associated with dyspnoea severity in fibrotic interstitial lung disease.
    Milne KM; Kwan JM; Guler S; Winstone TA; Le A; Khalil N; Camp PG; Wilcox PG; Ryerson CJ
    Respirology; 2017 May; 22(4):728-734. PubMed ID: 27860036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Dyspnea Visual Analog Scale in Fibrotic Interstitial Lung Disease.
    Bevanda L; Mok V; Lin K; Assayag D; Fisher JH; Johannson KA; Khalil N; Kolb M; Manganas H; Marcoux V; Sadatsafavi M; Wong AW; Ryerson CJ
    Ann Am Thorac Soc; 2024 Jul; 21(7):1007-1014. PubMed ID: 38315632
    [No Abstract]   [Full Text] [Related]  

  • 6. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease.
    Holland AE; Fiore JF; Bell EC; Goh N; Westall G; Symons K; Dowman L; Glaspole I
    Respirology; 2014 Nov; 19(8):1215-21. PubMed ID: 25112470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease.
    Swigris JJ; Yorke J; Sprunger DB; Swearingen C; Pincus T; du Bois RM; Brown KK; Fischer A
    Respir Med; 2010 Sep; 104(9):1350-5. PubMed ID: 20471238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire.
    Chung L; Chen H; Khanna D; Steen VD
    Arthritis Care Res (Hoboken); 2013 Mar; 65(3):454-63. PubMed ID: 23042670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.
    Chen T; Tsai APY; Hur SA; Wong AW; Sadatsafavi M; Fisher JH; Johannson KA; Assayag D; Morisset J; Shapera S; Khalil N; Fell CD; Manganas H; Cox G; To T; Gershon AS; Hambly N; Halayko AJ; Wilcox PG; Kolb M; Ryerson CJ
    Respir Res; 2021 Jul; 22(1):202. PubMed ID: 34238283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-related dyspnea is not modified by psychological status in people with COPD, interstitial lung disease or obesity.
    Sanchez O; Caumont-Prim A; Gillet-Juvin K; Callens E; Graba S; Essalhi M; Chevalier-Bidaud B; Israël-Biet D; Mahut B; Delclaux C
    Respir Physiol Neurobiol; 2012 Jun; 182(1):18-25. PubMed ID: 22366153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of health-related quality of life in patients with interstitial lung disease.
    Chang JA; Curtis JR; Patrick DL; Raghu G
    Chest; 1999 Nov; 116(5):1175-82. PubMed ID: 10559073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study.
    Ryerson CJ; Cayou C; Topp F; Hilling L; Camp PG; Wilcox PG; Khalil N; Collard HR; Garvey C
    Respir Med; 2014 Jan; 108(1):203-10. PubMed ID: 24332409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.
    Nagata K; Tomii K; Otsuka K; Tachikawa R; Otsuka K; Takeshita J; Tanaka K; Matsumoto T; Monden K
    Respirology; 2012 Apr; 17(3):506-12. PubMed ID: 22257381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual analogue scales for interstitial lung disease: a prospective validation study.
    Yates H; Adamali HI; Maskell N; Barratt S; Sharp C
    QJM; 2018 Aug; 111(8):531-539. PubMed ID: 29788503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of physical and mental health-related quality of life in patients with interstitial lung disease: a multifactorial analysis.
    Coelho AC; Knorst MM; Gazzana MB; Barreto SS
    J Bras Pneumol; 2010; 36(5):562-70. PubMed ID: 21085821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional assessment of the relationships between dyspnea domains and lung function in diffuse parenchymal lung disease.
    Londner C; Al Dandachi G; Plantier L; Gillet-Juvin K; Chevalier-Bidaud B; Mahut B; Israel-Biet D; Delclaux C
    Respiration; 2014; 87(2):105-12. PubMed ID: 23988331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.